首页 > 市场调查报告书 > 医疗设备

医学影像诊断内视镜检查设备

市场调查报告书

商品编码

1439692

内视镜 - 全球市场考量、竞争格局、市场预测 (2030)

Endoscopes - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按订单生产 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

预计2023年全球内视镜市场规模将达到129.5亿美元，到2030年将达到183.2亿美元，预计2024-2030年期间复合年增长率为6.05%。内视镜需求的增加主要是由于使用内视镜诊断胃肠道疾病，如肠躁症（IBD）、胃食道逆流（GERD）、消化性溃疡和克隆氏症。慢性病的流行、更容易患慢性病的老龄化人口的增加、以及对微创和无血手术的认识和需求的增加。诸如此类的内视镜技术的进步预计将增强市场并有助于2024-2030年预测期内内视镜市场的成长。

内视镜市场动态

在内视镜市场中，由于各种原因，产品需求不断增加。预计内视镜在各种应用中的使用增加将在预测期内加强内视镜市场。

内视镜可引起IBD、胃食道逆流症（GERD）、消化性溃疡、克隆氏症等慢性病的盛行率不断增加，因此其被应用于多种应用领域。

根据美国疾病管制与预防中心 (CDC) 2022 年发布的数据，2020 年诊断患有胃肠道溃疡的成年人人数估计为 1,480 万人。胃肠道溃疡包括消化性溃疡、食道溃疡和溃疡性结肠炎。根据美国癌症协会（2022）的数据，过去一年新诊断出食道癌约 20,640 例，其中男性估计为 16,510 例，女性为 4,130 例。食道癌的诊断是透过上消化道内视镜检查进行的。食道癌的盛行率很高，推动了内视镜市场的发展。

预测期内影响市场的另一个因素是人口老化的增加。据世界卫生组织称，2019年，60岁及以上的人口有10亿人。预计到 2030 年，这一数字将增至 14 亿，到 2050 年将增至 21 亿。这种成长正以前所未有的速度发生，预计在未来几十年将加速，特别是在发展中国家。罹患慢性病和癌症的可能性随着年龄的增长而增加，因此随着人口老化的增加，老年人口中慢性病的盛行率可能会增加，从而增加市场对产品的需求。

此外，人们对微创和无血手术的认识和需求的提高将增强内视镜市场。

因此，内视镜在各个应用领域的利用率不断提高，预计将增加对内视镜的需求并促进内视镜市场的成长。

然而，先进内视镜的操作问题、农村和发展中地区缺乏内视镜操作知识以及新一代仪器的高成本正在减缓内视镜市场的成长，这可能是一个限制因素。

持续的 COVID-19 大流行对内视镜市场产生了一些影响。疾病爆发之初，由于严格封锁以遏制病毒传播，出现了严重短缺。与 COVID-19 患者相比，癌症和其他慢性病患者的住院优先顺序较低。一些医疗器材的生产已停止。此外，在大流行期间，手术暂时停止。为了降低 COVID-19 传播的风险，内视镜中心已推迟或取消半紧急和选择性病例。然而，随着越来越多的人接种疫苗，内视镜市场正在恢復势头。

内视镜市场区隔分析

在内视镜市场的应用类型领域，胃肠内视镜预计在预测期内（2024-2030年）将占较大占有率。这可能是由于与这些设备相关的各种好处。

本报告研究和分析了全球内视镜市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

推动内视镜市场的因素
- 慢性病盛行率不断上升
- 更多用于慢性疾病的早期诊断，例如肠躁症 (IBD) 和胃食道逆流症 (GERD) 等胃肠道疾病
- 越来越多的老年人口容易罹患慢性病
- 人们对微创和无血手术的认识和需求不断提高
- 内视镜影像放大、高清光学系统、数位成像等方面的进展。
内视镜市场的抑制因素与挑战
- 内视镜成本高
- 缺乏操作先进设备的知识
内视镜市场机遇
- 机器人内视镜与一次内视镜的进展
- 欠发达国家市场的开发

第5章波特内视镜市场五力分析

第6章COVID-19对内视镜市场的影响分析

第7章内视镜市场布局

依弹性类型
- 软
- 硬
依一次性类型
- 一次性
- 可重复使用
依产品类型
- 传统方法
- 非传统方法
依使用型
- 胃肠道
- 耳鼻喉科
- 肿瘤
- 呼吸系统
- 妇科
- 泌尿科
- 其他
按最终用户
- 医院、诊所
- 门诊手术中心
按地区
- 北美
- 欧洲
- 亚太地区
- 其他领域

第 8 章内视镜市场：全球公司占有率分析 - 3 至 5 家主要公司

第9章内视镜市场公司与产品概况

Boston Scientific Corporation
CONMED Corporation
OLYMPUS CORPORATION
PENTAX Medical
FUJIFILM Holdings America Corporation
Stryker.
Karl Storz GmbH & Co., KG
Richard Wolf GmbH.
Medtronic
Machida Endoscope Co., Ltd
Pro Scope Systems
Laborie.
AED.MD
EMED
Happersberger otofront GmbH
Optomic.
EMOS Technology GmbH
Delmont imaging
Luxamed - Medical technology
Hangzhou Kangji Medical Instrument Co., Ltd
Daichuan medical

第10章KOL观看次数

第 11 章专案方法

第 12 章关于 DelveInsight

第 13 章免责声明与联络我们

简介目录图表

Product Code: DIMDCL0534

Endoscopes Market By Flexibity Type (Flexible And Rigid), By Disposability Type (Disposable And Reusable), By Product Type (Coventional [Bronchoscopes, Duedonescopes, Colonscopes, Cystoscopes, Rhinoscopes, And Others] And Non-Conventional [Capsule Endoscopes And Robort-Assisted Endoscopes]), By Application Type (Gastrointestinal, Ent, Oncology, Respiratory, Gynacology, Urology And Others), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers And Other), by geography is expected to grow at a steady cagr forecast till 2030 owing to increased prevalence of chronic diseases which require endoscopes for diagnosis and increased in early diagnosis and treatment of various cancers and some chronic diseases

Global endoscopes market was valued at USD 12.95 billion in 2023, growing at a CAGR of 6.05% during the forecast period from 2024 to 2030 to reach USD 18.32 billion by 2030. The increase in demand for endoscopes is primarily attributed to the increasing prevalence of chronic disease which require the use of endoscopes for diagnosis, such as some gastrointestinal diseases like irritable bowel syndrome (IBD), gastroesophageal reflux disease (GERD), peptic ulcer disease, and crohn's disease, increase in number of geriatric population who are more prone to chronic ailments, increasing awareness and demand of minimally invasive surgeries and no blood loss surgery, and rise in technological advancements in endoscopes like image magnification, high-definition optical systems and digital imaging are anticipated to bolster the market, thereby contributing to the growth of the endoscopes market during the forecast period from 2024-2030.

Endoscopes Market Dynamics:

The endoscopes market is witnessing a growth in product demand owing to various reasons. The increasing use of endoscopes in various applications is anticipated to bolster the market for endoscopes during the forecasted period.

Endoscopes had found their use in various areas of application attributed to increasing prevalence of chronic disorders like IBD, gastroesophageal reflux disease (GERD), peptic ulcer disease, and crohn's disease due to environmental pollution, smoking, unhealthy lifestyles, poor nutrition and diet, and high intake of carcinogenic substances.

According to Centers for Disease Control and Prevention (CDC) 2022, estimated that the number of adults with diagnosed gastrointestinal ulcers was 14.8 million in 2020. Gastorintetinal ulcers includes peptic ulcers, esophageal ulcer, ulcerative colitis and many more. According to American Cancer Society 2022, it was estimated that about 20,640 new esophageal cancer cases were diagnosed with 16,510 in men and 4,130 in women in past year. The diagnosis of esophageal cancer is done by upper endoscopy. The prevalence of esophageal cancer is higher, owing to propel the market of endoscopes.

Another factor which will affect the market in forecasting period is increasing number of geriatric population. According to WHO, in 2019, the number of people aged 60 years and older was 1 billion. This number is expected to increase to 1.4 billion by 2030 and 2.1 billion by 2050. This increase is occurring at an unprecedented pace and is expected to accelerate in coming decades, particularly in developing countries. The possibility of having a chronic disorder or cancer is higher in the older age, so as the number of geriatric population is increasing, this will increase the probability of increasing prevalence of a chronic ailment in geriatric population thereby owing to increase the product demand in the market.

Also, the increaseing awareness and demand of minimally invasive surgery and of no or less blood surgery will bolster the market of endoscopes.

Thus, due to the increasing utilization of endoscopes in various areas of application, there will be a rising demand for endoscopes, in turn increasing the endoscopes market growth.

However, problems in handling of the advanced endoscopes, less knowledge about operating the endoscopes in rural or under-developing area and high cost of new generation instruments may be certain limiting factors of the endoscopes market growth.

The ongoing COVID-19 pandemic has slightly impacted the market for endoscopes. At the onset of the disease, there was a significant shortage, attributed to the imposition of stringent lockdowns to curb the spread of the virus. Hospital admissions for patients suffering from cancers and other chronic disorders were not a priority in comparison to the patients suffering from coronavirus. Production of some medical devices was shutdown. Furthermore, surgeries were temporarily stopped during the pandemic. To reduce the COVID-19 transmission risk, endoscopy centers have postponed and canceled the semi-urgent and elective cases. However, with masses being vaccinated, the endoscopes market has picked momentum.

Endoscopes Market Segment Analysis:

Endoscopes Market by Flexibity Type (Flexible and Rigid), by Disposability Type (Disposable and Reusable), by Product Type (Coventional [Bronchoscopes, Duedonescopes, Colonscopes, Cystoscopes, Rhinoscopes, and Others] And Non-Conventional [Capsule Endoscopes and Robort-Assisted Endoscopes]), by Application Type (Gastrointestinal, ENT, Oncology, Respiratory, Gynacology, Urology and Others), by End-User (Hospitals And Clinics, Ambulatory Surgical Centers and Other) and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Application Type segment of the Endoscopes market, the Gastrointestinal endoscopy are estimated to hold a significant share in the Endoscopes market during the forecast period (2024-2030). This can be ascribed to the various advantages that are associated with these devices.

The demand for gastrointestinal endoscopes is expected to increase during the forecast period. This is owing to the rising prevalence of chronic disease such as inflammatory bowel disease (IBD), which is a group of disorder accompanied with chronic inflammation - pain and swelling - in intestine. IBD includes Crohn's disease and ulcerative colitis. According to Centers for Disease Control and Prevention (CDC) in 2022, a study concluded that the prevalence of IBD increased from 2001 to 2018 among all race and ethnicity groups, with a higher increase rate among non-Hispanic Black adults. It is estimated that the prevalence of IBD among U.S. population will rise to around 3.5 million by 2030, accounting for market growth of endoscopes.

Endoscopes also comprise technological advancements that enable the long and thin tube of endoscopes to enter the body through natural opening like mouth or by minimal by producing minimal cut in the body. These advancements increases the application of early diagnosis and treatment. According to Crohn's and Colitis Canada, 300,000 Canadians are having IBD. By 2030, the number of Canadians with IBD is expected to rise to 400,000 (approximately 1% of the population). Peope with age 65 years or above are calculated as the fastest growing group of Canadians with IBD. As per the same source, there are over 7,000 Canadian children - under age 18 - living with Crohn's or colitis. The prevalence of the above disorders can be controlled by encouraging and implementing the early diagnosis of these chronic disorders using endoscopes, thereby bolstering the market of endoscopes.

Thus, owing to the technological advancements in the area of endoscopes, there will be an increase in the demand for gastrointestinal endoscopes, which in turn will drive the endoscopes market growth.

North America is expected to dominate the overall Endoscopes Market:

Among all the regions, North America is expected to account for the largest share in the global Endoscopes market. Growing incidence of chronic diseases such as cancer, kidney disease, crohn's disease, improved healthcare expenditure, and the high geriatric population will increase the demand for endoscopes in North America, leading to a rise in the overall endoscopes market growth.

For instance, as per the National Cancer Institute 2020, an estimated number of 1,806,590 new cases of cancer were diagnosed in the United States and about 606,520 patients died from the disease. Also, as per the American Cancer Society 2020, 1.9 million new cancer cases were diagnosed. Moreover, according to CDC 2022, number of adults with diagnosed digestive ulcers were 14.8 million.

According to American Cancer Society's publication, Cancer Facts & Figures 2022, estimated that 20,640 adults were diagnosed with esophageal cancer in 2020. As the prevalence of cancers and digestive cancers and other GIT ailments like GERD, peptic ulcer and esophageal ulcer is increasing, this will increase the demand of endoscopes in the diagnosistic field thereby propelling the market of endoscopes in the North America.

Another driving factor for endoscope market will be the increasing number of geriatric population. According to Government of Canada 2022, by 2030 seniors are expected to over 9.5 million and make up 23% of Canadians. Moreover, as per the same source, by 2036, the average life expectancy at birth for women will rise to 86.2 years from the current 84.2 and to 82.9 years from the current 80 for men. Geriatric patients are more suseptable to cancer and chronic ailments owing to the increased diagnosis rate of these disorders. As the number of geriatric people is expected to increase in the forecast period a rise in demand of endosocopes in the market is seen in the forecast period in the region.

Thus, all the above-mentioned factors are anticipated to propel the market for Endoscopes in the North America.

Endoscopes Market Key Players:

Some of the key market players operating in the Endoscopes market include Boston Scientific Corporation, CONMED Corporation, OLYMPUS CORPORATION, PENTAX Medical, FUJIFILM Holdings America Corporation, Stryker., Karl Storz GmbH & Co., KG, Richard Wolf GmbH., Medtronic, Machida Endoscope Co., Ltd, Pro Scope Systems, Laborie., AED.MD, EMED, Happersberger otofront GmbH, Optomic., EMOS Technology GmbH, Delmont imaging, Luxamed - Medical technology, Hangzhou Kangji Medical Instrument Co.,Ltd., Daichuan medical, among others.

Recent Developmental Activities in the Endoscopes Market:

In March 2022, Shenzhen Xzing Technology Co. Ltd.'s was granted the National Medical Products Administration (NMPA's) class II approval for Endofresh disposable upper gastrointestinal (GI) endoscope. The approved product will be used for upper gastrointestinal GI endoscopy, diagnosis and treatment.

In November 2022, Medtronic plc announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its PillCam (Capsule endoscope) for remote endoscopy procedures.

In March 2019, Cook Medical and Ambu A/S entered into a partnership under which Cook will distribute Ambu's single-use, disposable duodenoscope in the U.S.

Key Takeaways from the Endoscopes Market Report Study

Market size analysis for current endoscopes market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Endoscopes market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the global endoscopes market.
Various opportunities available for the other competitor in the endoscopes market space.
What are the top performing segments in 2023? How these segments will perform in 2030.
Which is the top-performing regions and countries in the current endoscopes market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for endoscopes market growth in the coming future?

Target Audience who can be benefited from this Endoscopes Market Report Study

Endoscopes products providers
Research organizations and consulting companies
Endoscopes-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in endoscopes
Various End-users who want to know more about the endoscopes market and latest technological developments in the endoscopes market.

Frequently Asked Questions for Endoscopes Market:

1. What are Endoscopes?

Endoscopy is a medical procedure that is used to observe the inside of the body without performing major surgery. An endoscope is a long flexible tube with a lens at one end and a video camera at the other. The end with the lens is inserted into the patient. It is usually inserted through one of the body's natural openings, such as the mouth, urethra, or anus.

2. What is the market for Global Endoscopes?

Global endoscopes market was valued at USD 12.95 billion in 2023, growing at a CAGR of 6.05% during the forecast period from 2024 to 2030 to reach USD 18.32 billion by 2030.

3. What are the drivers for the Global Endoscopes Market?

The Endoscopes market is witnessing a positive market growth owing to the increasinged prevalence of chronic disease such as irritable bowel syndrome (IBD), gastroesophageal reflux disease (GERD), peptic ulcer disease, and crohn's disease, increase in number of prevalence of geriatric patient, increasinged awareness and demand of minimally invasive surgeries and no blood loss surgery for the treatment of chronic diseases, and rise in technological advancements in endoscopes like image magnification, high-definition optical systems and digital imaging across the world are anticipated to bolster the market.

4. Who are the key players operating in the Global Endoscopes Market?

5. Which region has the highest share in Endoscopes Market?

North America is expected to hold the highest share in the revenue in the Endoscopes market during the forecast period. Growing incidence of chronic diseases such as cancer, kidney disease, crohn's disease, improved healthcare expenditure, and the high geriatric population will increase the demand for endoscopes in North America, leading to a rise in the overall endoscopes market growth in this region.

1.Endoscopes Market Report Introduction

2.Endoscopes Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Endoscopes Market Key Factors Analysis

4.1. Endoscopes Market Drivers
- 4.1.1. Increasing Prevalence of Chronic Disease
- 4.1.2. Increased Application in Early Diagnosis of Chronic Diseases like in some Gastrointestinal Diseases such as Irritable Bowel Syndrome (IBD) and Gastroesophageal Reflux Disease (GERD)
- 4.1.3. Increase in the Number of Geriatric Population which are more prone to Chronic Ailements
- 4.1.4. Increasing Awareness and Demand of Minimally Invasive Surgeries and No Blood Loss Surgery
- 4.1.5. Rise in Technological Advancements like Image Magnification, High-Definition Optical Systems and Digital Imaging in Endoscopes
4.2. Endoscopes Market Restraints and Challenges
- 4.2.1. High Cost of Endoscopes
- 4.2.2. Less Knowledge About Operating the advanced Instruments
4.3. Endoscopes Market Opportunities
- 4.3.1. Advancements in Robotic and Disposable Endoscopes
- 4.3.2. Tapping the Underdeveloped Nation Market

5. Endoscopes Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Endoscopes Market

7. Endoscopes Market Layout

7.1. By Flexibity Type
- 7.1.1. Flexible
- 7.1.2. Rigid
7.2. By Disposability Type
- 7.2.1. Disposable
- 7.2.2. Reusable
7.3. By Product Type
- 7.3.1. Coventional
  - 7.3.1.1. Bronchoscopes
  - 7.3.1.2. Duedonescopes
  - 7.3.1.3. Colonscopes
  - 7.3.1.4. Cystoscopes
  - 7.3.1.5. Rhinoscopes
  - 7.3.1.6. Others
- 7.3.2 Non-conventional
  - 7.3.2.1. Capsule endoscopes
  - 7.3.2.2. Robort-assisted endoscopes
7.4. By Application Type
- 7.4.1. Gastrointestinal
- 7.4.2. ENT
- 7.4.3. Oncology
- 7.4.4. Respiratory
- 7.4.5. Gynacology
- 7.4.6. Urology
- 7.4.7. Others
7.5. By End User
- 7.5.1. Hospitals and Clinics
- 7.5.2. Ambulatory Surgical Centers
- 7.5.3. Others
7.6. By Geography
- 7.6.1. North America
  - 7.6.1.1. North America Endoscopes Market, by Country
  - 7.6.1.1.1. United States
  - 7.6.1.1.2. Canada
  - 7.6.1.1.3. Mexico
- 7.6.2. Europe
  - 7.6.2.1. Europe Endoscopes Market, by Country
  - 7.6.2.1.1. France
  - 7.6.2.1.2. Germany
  - 7.6.2.1.3. United Kingdom
  - 7.6.2.1.4. Italy
  - 7.6.2.1.5. Spain
  - 7.6.2.1.6. Russia
  - 7.6.2.1.7. Rest of Europe
- 7.6.3. Asia-Pacific
  - 7.6.3.1. Asia-Pacific Endoscopes Market, by Country
  - 7.6.3.1.1. China
  - 7.6.3.1.2. Japan
  - 7.6.3.1.3. India
  - 7.6.3.1.4. Australia
  - 7.6.3.1.5. South Korea
  - 7.6.3.1.6. Rest of Asia Pacific
- 7.6.4. Rest of the World (RoW)
  - 7.6.4.1. RoW Endoscopes Market, by Region
  - 7.6.4.1.1. Middle East
  - 7.6.4.1.2. Africa
  - 7.6.4.1.3. South America

8. Endoscopes MARKET Global Company Share Analysis - Key 3-5 Companies

9. Endoscopes Market Company and Product Profiles

9.1. Boston Scientific Corporation
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4. Product Listing
- 9.1.5. Entropy
9.2. CONMED Corporation
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4. Product Listing
- 9.2.5. Entropy
9.3. OLYMPUS CORPORATION
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4. Product Listing
- 9.3.5. Entropy
9.4. PENTAX Medical
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4. Product Listing
- 9.4.5. Entropy
9.5. FUJIFILM Holdings America Corporation
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4. Product Listing
- 9.5.5. Entropy
9.6. Stryker.
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4. Product Listing
- 9.6.5. Entropy
9.7. Karl Storz GmbH & Co., KG
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4. Product Listing
- 9.7.5. Entropy
9.8. Richard Wolf GmbH.
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4. Product Listing
- 9.8.5. Entropy
9.9. Medtronic
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4. Product Listing
- 9.9.5. Entropy
9.10. Machida Endoscope Co., Ltd
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4. Product Listing
- 9.10.5. Entropy
9.11. Pro Scope Systems
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4. Product Listing
- 9.11.5. Entropy
9.12. Laborie.
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4. Product Listing
- 9.12.5. Entropy
9.13. AED.MD
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4. Product Listing
- 9.13.5. Entropy
9.14. EMED
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4. Product Listing
- 9.14.5. Entropy
9.15. Happersberger otofront GmbH
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4. Product Listing
- 9.15.5. Entropy
9.16. Optomic.
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4. Product Listing
- 9.16.5. Entropy
9.17. EMOS Technology GmbH
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.4. Product Listing
- 9.17.5. Entropy
9.18. Delmont imaging
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4. Product Listing
- 9.18.5. Entropy
9.19. Luxamed - Medical technology
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4. Product Listing
- 9.19.5. Entropy
9.20. Hangzhou Kangji Medical Instrument Co., Ltd
- 9.20.1. Company Overview
- 9.20.2. Company Snapshot
- 9.20.3. Financial Overview
- 9.20.4. Product Listing
- 9.20.5. Entropy
9.21. Daichuan medical
- 9.21.1. Company Overview
- 9.21.2. Company Snapshot
- 9.21.3. Financial Overview
- 9.21.4. Product Listing
- 9.21.5. Entropy